![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
MannKind partners with drug discount app GoodRx
![](https://dev.pacbiztimes.com/wp-content/uploads/2017/06/15-mannkind-web-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Amgen discontinues Alzheimer’s prevention drug trials
![](https://dev.pacbiztimes.com/wp-content/uploads/2014/01/amgen-flagWEB-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Judge blocks rule requiring drug prices to be disclosed in TV ads
![](https://dev.pacbiztimes.com/wp-content/uploads/2018/09/26-amgen-worker-jump-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Nuevolution shareholders OK takeover by Amgen
![](https://dev.pacbiztimes.com/wp-content/uploads/2014/01/amgen-flagWEB-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Europeans nix Amgen’s Evenity over negative trial results
![](https://dev.pacbiztimes.com/wp-content/uploads/2014/01/amgen-flagWEB-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →